Press "esc" to clear
Go to Advanced Search

Showing results

110 of 879

Article ID: 699129

GW Researchers Publish Review Article on Developing Vaccines for Human Parasites

George Washington University

Researchers from the George Washington University published an article in Trends in Parasitology outlining their lessons learned while creating vaccine candidates for hookworm and schistosomiasis.

Released:
16-Aug-2018 3:05 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
  • Embargo expired:
    14-Aug-2018 11:00 AM EDT

Article ID: 698784

Mount Sinai Researchers Artificially Generate Immune Cells Integral to Creating Cancer Vaccines

Mount Sinai Health System

For the first time, Mount Sinai researchers have identified a way to make large numbers of immune cells that can help prevent cancer reoccurrence, according to a study published in August in Cell Reports.

Released:
9-Aug-2018 12:05 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
  • Embargo expired:
    10-Aug-2018 5:00 AM EDT

Article ID: 698777

Autoimmune Response Drives Vision Loss in Glaucoma

Massachusetts Eye and Ear

A research team from Massachusetts Eye and Ear and MIT has shown that immune cells in the eye that developed in response to early exposure to bacteria are a key contributor to progressive vision loss from glaucoma, the second leading cause of irreversible blindness in the world.

Released:
9-Aug-2018 12:05 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Article ID: 698593

Novel Vaccine Approach Proves Powerful Against Zika Virus

Ohio State University

A uniquely designed experimental vaccine against Zika virus has proven powerful in mice, new research has found.

Released:
6-Aug-2018 10:05 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
RS19058_IsabelScarinci-4-scr1.jpg

Article ID: 698532

Mobilizing the HPV vaccine

University of Alabama at Birmingham

Released:
3-Aug-2018 11:05 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
photo_4.jpg

Article ID: 698417

Ebola Virus - Subject Matter Experts

Georgetown University Medical Center

WASHINGTON — Georgetown University professors offer expertise for journalists seeking interviews in a variety of subjects related to Ebola. Topics include infectious disease control and treatment, vaccine development, clinical trials, global health security, and international health regulations. To schedule an interview, please contact Karen Teber at km463@georgetown.

Released:
1-Aug-2018 2:05 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
michaelmoore.jpg

Article ID: 698362

The Surge in Throat Cancer, Especially in Men

UC Davis Comprehensive Cancer Center

Humanpapilloma virus (HPV) is now the leading cause of certain types of throat cancer. Dr. Michael Moore, director of head and neck surgery at UC Davis and an HPV-related cancer expert, answers some tough questions about the trend and what can be done about it.

Released:
31-Jul-2018 6:05 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Article ID: 698333

Vaccines: The must-have on your child’s back-to-school checklist

University of Alabama at Birmingham

With the start of the school year just around the corner, it is easy to overlook one of the most important things on any back-to-school checklist — making sure your child is vaccinated.

Released:
31-Jul-2018 12:05 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
Feynman-Innovation-Awardee.jpg

Article ID: 697823

Promising Los Alamos Innovations Take the Spotlight

Los Alamos National Laboratory

Los Alamos scientist Bette Korber was recently honored with the 2018 Richard P. Feynman Innovation Prize for her ground-breaking HIV vaccine designs. Korber was recognized at a ceremony that celebrates the “Next Big Idea” – scientific breakthroughs that achieved exceptional innovation.

Released:
24-Jul-2018 10:05 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
  • Embargo expired:
    22-Jul-2018 8:00 AM EDT

Article ID: 697373

New MOF Vaccines Could Expand Access to Immunization and Reduce Global Health Care Costs

American Crystallographic Association (ACA)

Many vaccines become ineffective when exposed to room temperature or heat. This challenge can prevent patients from accessing lifesaving immunizations and increase the risk of global pandemics. During the 68th Annual Meeting of the American Crystallographic Association, Jeremiah Gassensmith, University of Texas at Dallas, will describe his lab’s work developing metal-organic framework vaccines. This new biocompatible polymer framework “freezes” proteins inside vaccines. The proteins then dissolve when injected in human skin. This innovation could help health care providers transport and administer vaccines in remote areas with unreliable power.

Released:
12-Jul-2018 2:05 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Showing results

110 of 879





Chat now!